• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.09% Nasdaq Up 0.14%

    CEL-SCI Corporation (CVM)

    -NYSE MKT
    0.76 Down 0.03(4.03%) 3:13PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.79
    Open:0.69
    Bid:0.76 x 100
    Ask:0.76 x 800
    1y Target Est:4.50
    Beta:-1.28
    Next Earnings Date:N/A
    Day's Range:0.68 - 0.76
    52wk Range:0.54 - 1.30
    Volume:6,100,590
    Avg Vol (3m):625,775
    Market Cap:69.53M
    P/E (ttm):N/A
    EPS (ttm):-0.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CVMDown 4.03%69.53M
    CLDXUp 2.47%2.74B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):251.63
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-0.40
    Quarterly EPS Est (Jun-15) :-0.10
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback